Satellos to Participate in November 2024 Investor Conferences
November 04 2024 - 7:30AM
Business Wire
Satellos Bioscience Inc. (“Satellos” or the “Company”) (TSX:
MSCL) (OTCQB: MSCLF), a public biotech company developing new small
molecule therapeutic approaches to improve the treatment of muscle
diseases and disorders, announced today that members of the
management team of the Company will participate in the following
investor conferences.
Guggenheim Securities Healthcare Innovation Conference
Format: Fireside Chat Date: Wednesday, November 13,
2024, at 3:30 p.m. ET
Stifel Healthcare Conference 2024 Format:
Presentation Date: Monday, November 18, 2024, at 9:45 a.m.
ET
Jefferies London Healthcare Conference 2024
Format: Participation in 1x1 meetings Dates: November
19 – 21, 2024
The fireside chat and presentation will be available via live
webcast on the Events and Presentations page in the Investors
section of the Company’s website and a replay will be available
following the events.
About Satellos Bioscience Inc.
Satellos is a publicly traded biotechnology company dedicated to
developing life-improving medicines to treat degenerative muscle
diseases. Satellos has incorporated breakthrough research in muscle
stem cell polarity into a proprietary discovery platform, called
MyoReGenX™, to identify degenerative muscle diseases where deficits
in this process affect muscle regeneration and are amenable to
therapeutic intervention. With this platform, Satellos is building
a pipeline of novel therapeutics to correct muscle stem cell
polarity and promote the body’s innate muscle repair and
regeneration process. The Company’s lead program is an oral, small
molecule drug candidate in development as a potential
disease-modifying treatment for Duchenne muscular dystrophy.
Satellos is headquartered in Toronto, Ontario. For more
information, visit www.satellos.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241104187364/en/
Investors: Liz Williams, CFO, ir@satellos.com Media: Jessica
Yingling, Ph.D., jessica@litldog.com, +1.858.344.8091
Satellos Bioscience (TSX:MSCL)
Historical Stock Chart
From Nov 2024 to Dec 2024
Satellos Bioscience (TSX:MSCL)
Historical Stock Chart
From Dec 2023 to Dec 2024